Nov 22, 2013, 13:10 PM by Michael Croft

Bio-IT World | Twin brothers Obi and Malachi Griffith have developed a free online database, the Drug Gene Interaction Database at dgidb.org, where researchers can quickly sort through the known drug interactions in the human genome.

Nov 20, 2013, 12:00 PM by Michael Croft

Bio-IT World | CLC bio, the world’s largest software developer for first-tier analysis of raw sequencing data, was recently acquired by QIAGEN and swept into a sequencing-to-informatics pipeline built around the still-unreleased GeneReader instrument. Big changes for this industry leader? Perhaps not.

Nov 20, 2013, 08:00 AM by Michael Croft

Bio-IT World Roundup | Yesterday the FDA granted premarket clearance to Illumina's MiSeqDx platform as well as several diagnostic kits to go with the platform.

Nov 20, 2013, 08:00 AM by Michael Croft

BBC | Frederick Sanger, two-time winner of the Nobel Prize and considered the "father of genomics", has died at the age of 95.

Nov 19, 2013, 12:00 PM by Michael Croft

Technology Review | Children’s Mercy Hospital in Kansas City has joined the ranks of pediatric hospitals actively using genome sequencing in their NICUs.

Nov 19, 2013, 08:00 AM by Michael Croft

Computerworld | The Top 500 supercomputer list was released yesterday. Tianhe-2 in China still holds the top spot with Oak Ridge National Laboratories' Titan in the number 2 spot.

Nov 18, 2013, 14:00 PM by Michael Croft

Xconomy | Luke Timmerman calls this the "stingiest funding cycle for first-time biotech financings in almost two decades."

Nov 18, 2013, 11:00 AM by Michael Croft

Bio-IT World Roundup | Several new updates emerged from Amazon Web Services at the user conference last week including Kinesis and AppStream.

Nov 15, 2013, 13:00 PM by Michael Croft

Bloomberg | Alzheimer's Research UK will fund a new drug discovery institute for dementia research.

Nov 15, 2013, 00:25 AM by Michael Croft

Bio-IT World News Brief | A new polymerase, PrimPol, joins previous Sygnis patent QualiPhi as the company establishes its niche in DNA amplification scenarios that the most commonly used polymerases have difficulty processing.

Nov 14, 2013, 11:20 AM by Michael Croft

Wired | NuMedii has been hard at work finding alternative uses for existing drugs. Human trials have now commenced to use the antidepressant imipramine on small-cell lung cancer.

Nov 14, 2013, 11:05 AM by Michael Croft

Molecular Cell | Michael Laub's lab at MIT is examining a bacterium's own toxin-antitoxin systems for clues to the development of novel antibiotics.

Nov 14, 2013, 08:00 AM by Michael Croft

Computerworld | At the Amazon Web Services Reinvent conference, Andy Jassy spared nothing in his assessment of private clouds, saying they offer "none of the benefits" of public cloud offerings.

Nov 14, 2013, 07:00 AM by Michael Croft

Bio-IT World News Brief | American philanthropists and entrepreneurs Eli and Edythe Broad are investing an additional $100 million into the Broad Institute to launch a new decade of transformative work to harness recent biomedical discoveries to benefit patients.

Nov 13, 2013, 12:00 PM by Michael Croft

Bio-IT World | Myriad Genetics got their fare share of press this summer when the Supreme Court ruled that Myriad’s gene patents were invalid. But in the past three months, the company has released three diagnostic and prognostic tests. Patent or no patent, they’ve been busy.

Nov 12, 2013, 12:15 PM by Michael Croft

ScienceWorksForU.S. | A survey of American research universities, conducted by a trio of higher education organizations, attempts to quantify where cuts to scientific research due to the sequester are being directed.

Nov 12, 2013, 12:00 PM by Michael Croft

Nov 12, 2013, 11:35 AM by Michael Croft

Bio-IT World | News briefs from around the industry, including new life science partnerships from Thomson Reuters, personalized diabetes care software at the UNC School of Medicine and SAS, and

Nov 12, 2013, 08:45 AM by Michael Croft

Bio-IT World News Brief | A paper published today in The Proceedings of the National Academy of Sciences suggests that many irreproducible findings in the scientific literature may be the result of a too-lenient standard for establishing statistical significance.

Nov 11, 2013, 20:00 PM by Michael Croft

Bio-IT World News Brief | Illumina today announced that Francis deSouza will take on the role of President, reporting to CEO Jay Flatley. deSouza will lead Illumina's business units and the core functions responsible for envisioning, developing and producing the company’s products. He will join the team in December.